Spotlight on perampanel in the management of seizures: design, development and an update on place in therapy
Michele A Faulkner1,2 1Department of Pharmacy Practice, 2Department of Neurology, Creighton University Schools of Pharmacy and Medicine, Omaha, NE, USA Purpose: Perampanel is a first-in-class antiepileptic medication approved for the treatment of partial (focal) seizures, and as adjunctive treatment...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-10-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/spotlight-on-perampanel-in-the-management-of-seizures-design-developme-peer-reviewed-article-DDDT |